glp-1 mood An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders glp 1 mood swings Psychotropic

Tingley, D., Yamamoto, T., Hirose, K., Keele, L

Wester continued, Given that the metabolic syndrome is a major driver of liver-related outcomes both in patients with MASLD and other chronic liver diseases such as alcohol-related liver disease or viral hepatitis C, there could be a similar effect of GLP1 agonists in patients with chronic liver diseases of any etiology with concomitant metabolic traits, such as type 2 diabetes. Using data from the Decoding the Epidemiology of LIVER disease Swedish cohort, researchers aimed to determine the long-term risk for major adverse liver outcomes (MALO) among patients with chronic liver disease and type 2 diabetes who either initiated (n = 1,026) or did not initiate (n = 15,633) GLP1 agonists

neither carries a regulatory determination of efficacy or safety for human therapeutic use

the spectrum of impairments noted in this disorder have coined the umbrella term "Autism Spectrum Disorder (ASD)